Skip to main content
Clinical Trials/CTRI/2020/07/026410
CTRI/2020/07/026410Not yet recruitingPhase 2

A Randomized Control Open Label Clinical Trial On The Efficacy Of Shatapushpa Churna And Madhutailika Basti In Nashtartava w.s.r. To Polycystic Ovarian Syndrome

ational Institute of Ayurveda Jaipur0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Patients willing to give voluntary informed consent.
  • Both married and unmarried patients.
  • ASRM/ESHRE (Rotterdam) Criteria,2013- Affected individuals must have two out of three criteria
  • 1. Oligo and /or anovulation
  • 2. Hyperandrogenism (clinical and /or biochemical).
  • 3. Polycystic ovaries(Confirmed on USG).

Exclusion Criteria

  • Patients not willing to give voluntary informed consent.
  • Women of age <18years and >40years.
  • Patients with chronic systemic illness (Congestive cardiac failure, Hypertension, cirrhosis of liver, chronic renal disease, diabetes mellitus, Tuberculosis etc.).
  • Patients using oral contraceptive pills.
  • Patients with any organic reproductive system abnormalities (Excluded clinically and radiologically), pelvic inflammatory disease, hydrosalpinx, endometriosis, adenomyosis, fibroid uterus, carcinoma of reproductive organ.
  • Any type of malignancy.
  • Patients with positive Sexually transmitted diseases (STDs), Human Immunodeficiency Virus HIV, Hepatitis B Surface Antigen(HbsAg).
  • Patients suffering from adrenal hyperplasia, severe insulin resistance, androgen secreting neoplasm, thyroid abnormalities, Cushingâ??s syndrome.

Investigators

Sponsor
ational Institute of Ayurveda Jaipur

Similar Trials